Trade Summary

3 days ago, Paolini John F., serving as CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, Plc (KNSA), sold 40,000 shares at $44.82 per share, for a total transaction value of $1,792,940.00. Following this transaction, Paolini John F. now holds 61,324 shares of KNSA.

This sale represents a 39.00% decrease in Paolini John F.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Kiniksa Pharmaceuticals International, Plc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.